Skip to main content

Diagnostic options · UAE

Genetic Sequencing tests in Dubai & UAE

Compare available Genetic Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

256

Listed price range

2,600.00–5,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Sequencing test prices

Showing 76–90 of 256 matching tests.

Genetic Sequencing diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3890
EFCAB13 Gene Autism Genetic Test

This test examines the entire coding region of the EFCAB13 gene using Next Generation Sequencing to identify pathogenic variants linked to Autism Spectrum Disorder.

Peripheral Whole Blood (FTA Card or Venipuncture) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the EFCAB13 gene", "Single nucleotide variants", "Small insertions", "Small deletions"]
Parameters
[]
Preparation
["Pre-test genetic counseling is mandatory", "Establish a three-generation pedigree"]
Indications
["Clinical suspicion of Autism Spectrum Disorder", "Familial risk assessment for neurodevelopmental conditions", "Guiding early intervention strategies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 51966-6 ICD-10: F84.0
Clinical summary
This test examines the entire coding region of the EFCAB13 gene using Next Generation Sequencing to identify pathogenic variants linked to Autism Spectrum Disorder.
TEST-4488
EIF2AK3 Gene (Wolcott‑Rallison Syndrome) Genetic Test

This genetic test detects pathogenic variants in the EIF2AK3 gene, confirming the diagnosis of Wolcott‑Rallison syndrome.

Whole blood (EDTA) or extracted genomic DNA 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the EIF2AK3 gene"]
Parameters
[]
Preparation
["Mandatory genetic counseling session", "Complete clinical history and pedigree chart"]
Indications
["Suspected Wolcott‑Rallison syndrome", "Family history of Wolcott‑Rallison syndrome", "Neonatal diabetes with skeletal or liver abnormalities"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48020-7 ICD-10: Q87.1
Clinical summary
This genetic test detects pathogenic variants in the EIF2AK3 gene, confirming the diagnosis of Wolcott‑Rallison syndrome.
TEST-4788
EIF2B4 Gene Leukoencephalopathy with Vanishing White Matter (Genetic Test)

This genetic test identifies pathogenic variants in the EIF2B4 gene, the established molecular cause of Leukoencephalopathy with Vanishing White Matter (VWM).

Peripheral Whole Blood (EDTA) or FTA Card Blood Spot 21–28 calendar days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the EIF2B4 gene", "Coding exons and flanking intronic regions of the EIF2B4 gene"]
Parameters
[]
Preparation
["No specific fasting required", "No specific medication or diet restrictions"]
Indications
["Individuals of any age presenting with unexplained neurological regression", "Individuals with cerebellar ataxia", "Individuals with spasticity", "Individuals with diagnostic MRI findings suggestive of a leukodystrophy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21665-5 ICD-10: E75.2
Clinical summary
This genetic test identifies pathogenic variants in the EIF2B4 gene, the established molecular cause of Leukoencephalopathy with Vanishing White Matter (VWM).
TEST-3996
ELN Gene Supravalvar Aortic Stenosis Genetic Test

This genetic test identifies pathogenic variants in the ELN gene associated with supravalvular aortic stenosis and Williams syndrome.

Whole blood (EDTA tube), extracted DNA, or FTA card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ELN gene"]
Parameters
[]
Preparation
["No fasting required", "No medication stoppage unless advised by physician"]
Indications
["Diagnosis of SVAS", "Diagnosis of Williams syndrome", "Familial risk assessment for ELN-related disorders", "Genetic counseling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94745-7 ICD-10: Q25.3, Z15.89, Z13.79
Clinical summary
This genetic test identifies pathogenic variants in the ELN gene associated with supravalvular aortic stenosis and Williams syndrome.
TEST-4586
ELP1 Gene HSAN3 Genetic Test

This test analyzes the ELP1 gene for pathogenic variants associated with Hereditary Sensory and Autonomic Neuropathy Type III (Familial Dysautonomia). It provides a definitive mole...

Whole Blood (Peripheral), Dried Blood Spot (FTA Card), or Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ELP1 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variants (CNVs)"]
Parameters
[]
Preparation
["No fasting required", "Complete a pre-test genetic counseling session", "Provide a three-generation pedigree"]
Indications
["Diagnosis of Hereditary Sensory and Autonomic Neuropathy Type III (Familial Dysautonomia)", "Carrier screening in families with a history of the condition", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94740-6 ICD-10: G90.1
Clinical summary
This test analyzes the ELP1 gene for pathogenic variants associated with Hereditary Sensory and Autonomic Neuropathy Type III (Familial Dysautonomia). It provides a definitive molecular diagnosis.
TEST-2366
EMX2 Gene Schizencephaly Next-Generation Sequencing (NGS) Genetic Test

This test identifies pathogenic variants within the EMX2 gene associated with schizencephaly.

Whole Blood (EDTA), Extracted Genomic DNA, or FTA Card Blood Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in EMX2 coding region", "Pathogenic variants in EMX2 conserved splice sites"]
Parameters
[]
Preparation
["No fasting or special preparation required", "Pre-test genetic counseling recommended for minors"]
Indications
["Diagnosis of schizencephaly", "Recurrence risk estimation", "Informed family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: Q04.6
Clinical summary
This test identifies pathogenic variants within the EMX2 gene associated with schizencephaly.
TEST-5456
ENAM Gene Amelogenesis Imperfecta Type 1B Genetic Test

This genetic test identifies pathogenic variants in the ENAM gene associated with Amelogenesis Imperfecta Type 1B.

Whole Blood (EDTA) or Buccal Swab 21–28 Days (3–4 Weeks) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ENAM gene", "Mutations causing enamel defects"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any bleeding disorders"]
Indications
["Suspected Amelogenesis Imperfecta Type 1B", "Family history of enamel defects", "Need for genetic counseling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: K00.5, K00.4
Clinical summary
This genetic test identifies pathogenic variants in the ENAM gene associated with Amelogenesis Imperfecta Type 1B.
TEST-5410
ENAM Gene Amelogenesis Imperfecta Type 1C Genetic Test

This test identifies pathogenic variants in the ENAM gene associated with hypocalcified amelogenesis imperfecta.

Whole blood or Dried Blood Spot (FTA Card) 3–4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ENAM gene", "Point mutations", "Small insertions/deletions", "Copy number variants"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any bleeding disorders"]
Indications
["Suspected diagnosis of amelogenesis imperfecta type 1C", "Family history of amelogenesis imperfecta", "Need for genetic counseling and family risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81261-8 ICD-10: K00.4
Clinical summary
This test identifies pathogenic variants in the ENAM gene associated with hypocalcified amelogenesis imperfecta.
TEST-4519
ERCC3 Gene Trichothiodystrophy Genetic Test

This genetic test identifies pathogenic variants in the ERCC3 gene associated with Trichothiodystrophy (TTD). It utilizes Next-Generation Sequencing (NGS) for comprehensive analysi...

Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ERCC3 gene", "Point mutations", "Small insertions/deletions", "Copy-number variations"]
Parameters
[]
Preparation
["Pre-test genetic counselling session required", "Family pedigree chart required"]
Indications
["Suspected Trichothiodystrophy (TTD)", "Need for definitive molecular diagnosis", "Patient stratification", "Personalized management planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55182-4 ICD-10: Q87.1, Z15.09, Q82.8
Clinical summary
This genetic test identifies pathogenic variants in the ERCC3 gene associated with Trichothiodystrophy (TTD). It utilizes Next-Generation Sequencing (NGS) for comprehensive analysis.
TEST-3051
ERCC6L2 Gene Bone Marrow Failure Syndrome Type 2 Genetic Test

This test evaluates the ERCC6L2 gene for pathogenic variants associated with inherited bone marrow failure syndrome type 2.

Peripheral whole blood 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic germline variants in the ERCC6L2 gene", "Full coding region and splice junctions of ERCC6L2"]
Parameters
[]
Preparation
["A comprehensive clinical history must be reviewed", "A three-generation pedigree chart must be reviewed"]
Indications
["Diagnosis of inherited bone marrow failure syndrome type 2", "Carrier detection", "Cascade screening of at-risk relatives"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 59009-0 ICD-10: D61.09
Clinical summary
This test evaluates the ERCC6L2 gene for pathogenic variants associated with inherited bone marrow failure syndrome type 2.
TEST-2962
ERCC8 Gene (Cockayne Syndrome Type A) Genetic Test

This genetic test evaluates the entire coding region of the ERCC8 gene for pathogenic variants associated with Cockayne syndrome type A.

Peripheral whole blood (EDTA), DNA FTA card, or extracted genomic DNA 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ERCC8 gene sequence", "Copy Number Variations (CNV) in ERCC8"]
Parameters
[]
Preparation
[]
Indications
["Paediatric patients with clinical features suggestive of Cockayne syndrome", "Siblings of a confirmed case", "Parents seeking carrier testing"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82938-9 ICD-10: Q87.1, Z15.09, E34.3
Clinical summary
This genetic test evaluates the entire coding region of the ERCC8 gene for pathogenic variants associated with Cockayne syndrome type A.
TEST-2376
ESCO2 Gene Sequencing for SC Phocomelia Syndrome (Roberts Syndrome) Test

This diagnostic test evaluates the ESCO2 gene for mutations causing SC Phocomelia syndrome (Roberts syndrome). It identifies pathogenic variants and copy number variations.

Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ESCO2 gene sequence", "Copy Number Variations (CNVs) in ESCO2 gene"]
Parameters
[]
Preparation
["Detailed clinical history required", "Three-generation pedigree required", "Pre-test genetic counseling session mandatory"]
Indications
["Clinical suspicion of SC Phocomelia syndrome (Roberts syndrome)", "Carrier screening for individuals with a family history", "Prenatal diagnosis planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82939-1 ICD-10: Q87.2, Z15.89, Z13.71
Clinical summary
This diagnostic test evaluates the ESCO2 gene for mutations causing SC Phocomelia syndrome (Roberts syndrome). It identifies pathogenic variants and copy number variations.
TEST-5959
ETFB Gene Acyl-CoA Multiple Dehydrogenase Deficiency Genetic Test

This genetic test evaluates the ETFB gene for mutations associated with Multiple Acyl-CoA Dehydrogenase Deficiency (MADD). It identifies pathogenic variants that disrupt fatty acid...

Peripheral whole blood (EDTA) or FTA card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ETFB gene", "Fatty acid oxidation pathway disruption"]
Parameters
[]
Preparation
["Genetic counseling session required", "Family pedigree chart required", "Detailed clinical history required", "Informed consent required", "Blood draw (EDTA) or FTA card required"]
Indications
["Suspected Multiple Acyl-CoA Dehydrogenase Deficiency (MADD)", "Family history of MADD", "Metabolic crisis of unknown origin"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94299-1 ICD-10: E71.313
Clinical summary
This genetic test evaluates the ETFB gene for mutations associated with Multiple Acyl-CoA Dehydrogenase Deficiency (MADD). It identifies pathogenic variants that disrupt fatty acid oxidation.
TEST-5581
EXOSC3 Gene Pontocerebellar Hypoplasia Type 1B Genetic Test

This genetic test analyzes the EXOSC3 gene to identify mutations causing Pontocerebellar Hypoplasia Type 1B.

Peripheral Whole Blood (Venipuncture or FTA Card) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["EXOSC3 gene coding region", "Pathogenic variants in EXOSC3"]
Parameters
[]
Preparation
["No fasting required", "Prior genetic counselling session is mandatory", "Pedigree charting call before sample collection"]
Indications
["Suspected Pontocerebellar Hypoplasia Type 1B", "Confirmation of clinical diagnosis", "Genetic counselling", "Family planning", "Carrier screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82157-4 ICD-10: Q04.8
Clinical summary
This genetic test analyzes the EXOSC3 gene to identify mutations causing Pontocerebellar Hypoplasia Type 1B.
TEST-4692
EXOSC8 Gene (Joubert Syndrome) Genetic Test

This test evaluates the EXOSC8 gene for pathogenic variants associated with Joubert syndrome.

Peripheral Whole Blood (EDTA Vacutainer) / Saliva (Buccal Swab) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the EXOSC8 gene", "Full gene coverage including intronic regions"]
Parameters
[]
Preparation
["No specific fasting required", "No medication adjustments needed unless advised by physician"]
Indications
["Suspected Joubert syndrome based on clinical presentation", "Family history of Joubert syndrome", "Need for definitive molecular diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 87818-5 ICD-10: Q04.3
Clinical summary
This test evaluates the EXOSC8 gene for pathogenic variants associated with Joubert syndrome.

Category overview

Genetic Sequencing: overview

Achieving a definitive diagnosis for multi-system or exceptionally rare disorders requires reading the deepest layers of your foundational biological code. As the pinnacle of our advanced Genetics department, Genetic Sequencing (including Whole Exome or Whole Genome testing) provides an incredibly detailed, high-resolution scan of your DNA. By leveraging state-of-the-art Next-Generation Sequencing technology, this expansive molecular screening helps uncover elusive genetic variants that standard tests miss, safely guiding your healthcare provider in tailoring highly personalized medical treatments and opening doors to advanced precision medicine. Consistently trusted for advanced genomic analysis across premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, exceptional analytical precision, and highly efficient reporting. Secure the definitive insights your health requires—book your genetic sequencing testing in UAE, arrange a secure clinical sample collection, or consult our dedicated medical genetics experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.